AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pizarro, F.
Right arrow Articles by Gidi, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pizarro, F.
Right arrow Articles by Gidi, V.
Agricola
Right arrow Articles by Pizarro, F.
Right arrow Articles by Gidi, V.
American Journal of Clinical Nutrition, Vol. 76, No. 3, 577-581, September 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Iron bis-glycine chelate competes for the nonheme-iron absorption pathway1,2,3

Fernando Pizarro, Manuel Olivares, Eva Hertrampf, Dora I Mazariegos, Miguel Arredondo, Angélica Letelier and Virginia Gidi

1 From the Institute of Nutrition and Food Technology, the University of Chile, Santiago (FP, MO, EH, DIM, MA, and AL), and the US Department of Health and Human Services, Washington, DC (VG).

Background: The enterocytic absorption pathway of the food fortificant iron bis-glycine chelate has been the subject of controversy because it is not clear whether that substance uses the classic nonheme-iron absorption pathway or a pathway similar to that of heme absorption.

Objective: The objective was to study the absorption pathway of iron bis-glycine chelate in human subjects.

Design: Eighty-five healthy adult women were selected to participate in 1 of 6 iron-absorption studies. Study A involved the measurement of the dose-response curve of the absorption of ferrous sulfate (through a nonheme-iron absorption pathway); study B involved the competition of iron bis-glycine chelate with ferrous sulfate for the nonheme-iron absorption pathway; study C involved the measurement of the dose-response curve of heme-iron absorption; study D involved the competition of iron bis-glycine chelate with hemoglobin for the heme-iron absorption pathway; and studies E and F were the same as studies A and B, except that the iron bis-glycine chelate was encapsulated in enteric gelatin capsules so that it would not be processed in the stomach.

Results: Iron from the bis-glycine chelate competed with ferrous sulfate for the nonheme-iron absorption pathway. Iron from the bis-glycine chelate also competed with ferrous sulfate for absorption when liberated directly into the intestinal lumen. Iron from the bis-glycine chelate did not compete with heme iron for the heme-iron absorption pathway.

Conclusion: The iron from iron bis-glycine chelate delivered at the level of the stomach or duodenum becomes part of the nonheme-iron pool and is absorbed as such.

Key Words: Iron bioavailability • iron absorption • ferrous bis-glycine • iron amino acid chelate • iron fortification • iron status




This article has been cited by other articles:


Home page
J. Nutr.Home page
J. H. Swain, L. K. Johnson, and J. R. Hunt
Electrolytic Iron or Ferrous Sulfate Increase Body Iron in Women with Moderate to Low Iron Stores
J. Nutr., March 1, 2007; 137(3): 620 - 627.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. I. Mazariegos, F. Pizarro, M. Olivares, M. T. Nunez, and M. Arredondo
The Mechanisms for Regulating Absorption of Fe Bis-Glycine Chelate and Fe-Ascorbate in Caco-2 Cells Are Similar
J. Nutr., February 1, 2004; 134(2): 395 - 398.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
O. Pineda
Iron bis-glycine chelate competes for the nonheme-iron absorption pathway
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 495 - 496.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
F. Pizarro, M. Olivares, E. Hertrampf, and M. Arredondo
Reply to O Pineda
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 496 - 496.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition